Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

A factorial analysis of the combined effects of hydrogel fabrication parameters on the in vitro swelling and degradation of oligo(poly(ethylene glycol) fumarate) hydrogels.

Lam J, Kim K, Lu S, Tabata Y, Scott DW, Mikos AG, Kasper FK.

J Biomed Mater Res A. 2014 Oct;102(10):3477-87. doi: 10.1002/jbm.a.35015. Epub 2013 Nov 15.

PMID:
24243766
[PubMed - in process]
2.

In vivo bone and soft tissue response to injectable, biodegradable oligo(poly(ethylene glycol) fumarate) hydrogels.

Shin H, Quinten Ruhé P, Mikos AG, Jansen JA.

Biomaterials. 2003 Aug;24(19):3201-11.

PMID:
12763447
[PubMed - indexed for MEDLINE]
3.

Effect of swelling ratio of injectable hydrogel composites on chondrogenic differentiation of encapsulated rabbit marrow mesenchymal stem cells in vitro.

Park H, Guo X, Temenoff JS, Tabata Y, Caplan AI, Kasper FK, Mikos AG.

Biomacromolecules. 2009 Mar 9;10(3):541-6. doi: 10.1021/bm801197m.

PMID:
19173557
[PubMed - indexed for MEDLINE]
Free PMC Article
4.
5.

Degradative properties and cytocompatibility of a mixed-mode hydrogel containing oligo[poly(ethylene glycol)fumarate] and poly(ethylene glycol)dithiol.

Brink KS, Yang PJ, Temenoff JS.

Acta Biomater. 2009 Feb;5(2):570-9. doi: 10.1016/j.actbio.2008.09.015. Epub 2008 Oct 4.

PMID:
18948068
[PubMed - indexed for MEDLINE]
6.

In vitro cytotoxicity of unsaturated oligo[poly(ethylene glycol) fumarate] macromers and their cross-linked hydrogels.

Shin H, Temenoff JS, Mikos AG.

Biomacromolecules. 2003 May-Jun;4(3):552-60.

PMID:
12741769
[PubMed - indexed for MEDLINE]
7.

Effect of poly(ethylene glycol) molecular weight on tensile and swelling properties of oligo(poly(ethylene glycol) fumarate) hydrogels for cartilage tissue engineering.

Temenoff JS, Athanasiou KA, LeBaron RG, Mikos AG.

J Biomed Mater Res. 2002 Mar 5;59(3):429-37.

PMID:
11774300
[PubMed - indexed for MEDLINE]
8.

Bone morphogenetic protein-2 release from composite hydrogels of oligo(poly(ethylene glycol) fumarate) and gelatin.

Kinard LA, Chu CY, Tabata Y, Kasper FK, Mikos AG.

Pharm Res. 2013 Sep;30(9):2332-43. doi: 10.1007/s11095-013-1077-5. Epub 2013 May 18.

PMID:
23686376
[PubMed - indexed for MEDLINE]
9.

Transforming growth factor-beta 1 release from oligo(poly(ethylene glycol) fumarate) hydrogels in conditions that model the cartilage wound healing environment.

Holland TA, Tessmar JK, Tabata Y, Mikos AG.

J Control Release. 2004 Jan 8;94(1):101-14.

PMID:
14684275
[PubMed - indexed for MEDLINE]
10.

Effect of drying history on swelling properties and cell attachment to oligo(poly(ethylene glycol) fumarate) hydrogels for guided tissue regeneration applications.

Temenoff JS, Steinbis ES, Mikos AG.

J Biomater Sci Polym Ed. 2003;14(9):989-1004.

PMID:
14661875
[PubMed - indexed for MEDLINE]
11.

Characterization of DNA release from composites of oligo(poly(ethylene glycol) fumarate) and cationized gelatin microspheres in vitro.

Kasper FK, Jerkins E, Tanahashi K, Barry MA, Tabata Y, Mikos AG.

J Biomed Mater Res A. 2006 Sep 15;78(4):823-35.

PMID:
16741980
[PubMed - indexed for MEDLINE]
12.
13.

Determination of the in vivo degradation mechanism of PEGDA hydrogels.

Browning MB, Cereceres SN, Luong PT, Cosgriff-Hernandez EM.

J Biomed Mater Res A. 2014 Jan 27. doi: 10.1002/jbm.a.35096. [Epub ahead of print]

PMID:
24464985
[PubMed - as supplied by publisher]
14.

Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering.

Holland TA, Tabata Y, Mikos AG.

J Control Release. 2005 Jan 3;101(1-3):111-25.

PMID:
15588898
[PubMed - indexed for MEDLINE]
15.

Effect of dual growth factor delivery on chondrogenic differentiation of rabbit marrow mesenchymal stem cells encapsulated in injectable hydrogel composites.

Park H, Temenoff JS, Tabata Y, Caplan AI, Raphael RM, Jansen JA, Mikos AG.

J Biomed Mater Res A. 2009 Mar 15;88(4):889-97. doi: 10.1002/jbm.a.31948.

PMID:
18381637
[PubMed - indexed for MEDLINE]
16.

Thermally cross-linked oligo(poly(ethylene glycol) fumarate) hydrogels support osteogenic differentiation of encapsulated marrow stromal cells in vitro.

Temenoff JS, Park H, Jabbari E, Conway DE, Sheffield TL, Ambrose CG, Mikos AG.

Biomacromolecules. 2004 Jan-Feb;5(1):5-10.

PMID:
14715001
[PubMed - indexed for MEDLINE]
17.

In vitro release of plasmid DNA from oligo(poly(ethylene glycol) fumarate) hydrogels.

Kasper FK, Seidlits SK, Tang A, Crowther RS, Carney DH, Barry MA, Mikos AG.

J Control Release. 2005 Jun 2;104(3):521-39. Epub 2005 Apr 26.

PMID:
15911051
[PubMed - indexed for MEDLINE]
18.

Bioactive hydrogels made from step-growth derived PEG-peptide macromers.

Miller JS, Shen CJ, Legant WR, Baranski JD, Blakely BL, Chen CS.

Biomaterials. 2010 May;31(13):3736-43. doi: 10.1016/j.biomaterials.2010.01.058. Epub 2010 Feb 6.

PMID:
20138664
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Tailoring the degradation of hydrogels formed from multivinyl poly(ethylene glycol) and poly(vinyl alcohol) macromers for cartilage tissue engineering.

Martens PJ, Bryant SJ, Anseth KS.

Biomacromolecules. 2003 Mar-Apr;4(2):283-92.

PMID:
12625723
[PubMed - indexed for MEDLINE]
20.

Characterization of photo-cross-linked oligo[poly(ethylene glycol) fumarate] hydrogels for cartilage tissue engineering.

Dadsetan M, Szatkowski JP, Yaszemski MJ, Lu L.

Biomacromolecules. 2007 May;8(5):1702-9. Epub 2007 Apr 10.

PMID:
17419584
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk